Skip to search formSkip to main contentSkip to account menu

CV 4151

Known as: CV-4151 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

isbogrel

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1996
1996
Effect of CV-4151 (Isbogrel), a Thromboxane A2 Synthase Inhibitor, on Bleeding Time in Rats
Effect of CV-4151, a thromboxane A2 synthase inhibitor, on antithrombotic and thrombolytic agents-induced bleeding time… 
1996
1996
Effects of thromboxane A2 synthase inhibitors, CV-4151 and sodium ozagrel, on prostanoid metabolism Studies in patients withacute cerebral thrombosis.
脳血栓症急性患者14名を2群 (各7例) に分け, トロンボキサン (TX) A2合成酵素阻害薬CV-4151を100mg/日 (C群) あるいはオザグレルナトリウム160mg/日 (O群) を14… 
1996
1996
CV-4151(イスボグレル),トロンボキサンA_2合成酵素阻害薬のラット出血時間におよぼす影響 : 抗血小板薬,抗凝固薬および血栓溶解薬との併用効果
1994
1994
Effects of thromboxane A[2] synthetase inhibitor (CV-4151) on reperfused skeletal muscle in rats
1990
1990
-0695-RANDOMIZED TRIAIL OF A SELECTIVE INHIBITOR OF THROMBOXANE A_2 SYNTHETASE, (E)-7-PHENYL-7-(3-PYRIDYL)-6-HEPTENOIC ACID (CV-4151) FOR PREVENTION OF RESTENOSIS AFTER PTCA
1986
1986
Protective effect of a novel thromboxane synthetase inhibitor, CV-4151, on myocardial damage due to coronary occlusion and reperfusion in the hearts of anesthetized dogs.
The protective effect of a novel thromboxane (TX) synthetase inhibitor, (E)-7-phenyl-7-(3-pyridyl)-6-heptenoic acid (CV-4151), on… 
1985
1985
(E)-7-Phenyl-7-(3-pyridyl)-6-heptenoic acid (CV-4151): a potent, specific thromboxane A2 synthetase inhibitor.